The Ohio State Buckeyes have landed one of their two biggest fish in the 2024 recruiting class. Five-star receiver Mylan Graham penned his letter of intent with the Buckeyes on Wednesday during early ...

As India and the Philippines celebrated 75 years of diplomatic relations, the Ministry of External Affairs (MEA) unveiled a special logo to commemorate the milestone. The logo, shared by MEA ...

DUBLIN, Nov. 12, 2024 /PRNewswire/ -- Theravance Biopharma, Inc. ("Theravance Biopharma" or the "Company") (NASDAQ: TBPH) today reported financial and operational results for the third quarter of 2024 ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

In a report released today, Balaji Prasad from Barclays maintained a Sell rating on Viatris (VTRS – Research Report), with a price target ...

TME Pharma will be able to optimize late phase development by selecting the best performing treatment arm against standard of care. The Phase 2 results will serve as a basis for discussions with ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Mallinckrodt Pharmaceuticals, Mylan Pharmaceutical AG and Medtronic Sandoz is involved in research and development efforts related to endocrine disorders, including adrenal insufficiency. The company ...

New Delhi: Mylan Laboratories has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) to manufacture and market Epinephrine ...

Vertex Pharmaceuticals is in the process of getting a new painkiller approved. It just published some data that suggests the candidate will be quite profitable. But regulators still need to sign ...

On Thursday, Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) stock plunged after the company revealed disappointing data from the Phase 3 TrustTSC trial of oral ganaxolone for seizures associated with ...